# Invesco CurrencyShares Swiss Franc Trust: financial statements, quarterly

FXF · NYSE · CIK 1353615 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxf.md) · [Financials](/companies/fxf/financials.md) · [Filings](/companies/fxf/filings.md) · [Insiders](/companies/fxf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fxf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [69.9](/filings/0000950170-24-122605.md) | [249 d](/filings/0000950170-25-027267.md) | [212](/filings/0000950170-25-067208.md) | [92.6](/filings/0000950170-25-105146.md) | [93.3](/filings/0001193125-25-270296.md) | [60.8 d](/filings/0001193125-26-083569.md) | [0.0](/filings/0001193125-26-209714.md) | [0.0](/filings/0001193125-26-338693.md) | [0.0](/filings/0001193125-25-270296.md) | [0.0 d](/filings/0001193125-26-083569.md) | [0.0](/filings/0001193125-26-209714.md) | [0.0](/filings/0001193125-26-338693.md) |
| Interest expense | $k | [0.0](/filings/0000950170-24-122605.md) | [0.0 d](/filings/0000950170-25-027267.md) | not reported | [0.0](/filings/0000950170-24-092133.md) | [0.0](/filings/0000950170-24-122605.md) | [0.0 d](/filings/0000950170-25-027267.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0 d](/filings/0000950170-23-060483.md) | [0.0 d](/filings/0000950170-24-019055.md) | [0.0](/filings/0000950170-24-054965.md) | [0.0 d](/filings/0000950170-24-092133.md) | [0.0 d](/filings/0000950170-24-122605.md) | [0.0 d](/filings/0000950170-25-027267.md) | [0.0](/filings/0000950170-25-067208.md) | [0.0 d](/filings/0000950170-25-105146.md) | [0.0 d](/filings/0001193125-25-270296.md) | [0.0 d](/filings/0001193125-26-083569.md) | [0.0](/filings/0001193125-26-209714.md) | [0.0 d](/filings/0001193125-26-338693.md) |
| Net income | $k | [(110)](/filings/0000950170-24-122605.md) | [52.5 d](/filings/0000950170-25-027267.md) | [39.2](/filings/0000950170-25-067208.md) | [(53.3)](/filings/0000950170-25-105146.md) | [(54.9)](/filings/0001193125-25-270296.md) | [(89.3) d](/filings/0001193125-26-083569.md) | [(140)](/filings/0001193125-26-209714.md) | [(427)](/filings/0001193125-26-338693.md) | [(573)](/filings/0001193125-25-270296.md) | [(547) d](/filings/0001193125-26-083569.md) | [(680)](/filings/0001193125-26-209714.md) | [(677)](/filings/0001193125-26-338693.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0000950170-24-122605.md) | not reported | [0.02](/filings/0000950170-25-067208.md) | [(0.04)](/filings/0000950170-25-105146.md) | [(0.04)](/filings/0001193125-25-270296.md) | not reported | [(0.10)](/filings/0001193125-26-209714.md) | [(0.10)](/filings/0001193125-26-338693.md) | [(0.16)](/filings/0001193125-25-270296.md) | not reported | [(0.15)](/filings/0001193125-26-209714.md) | [(0.15)](/filings/0001193125-26-338693.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0000950170-24-122605.md) | not reported | [0.02](/filings/0000950170-25-067208.md) | [(0.04)](/filings/0000950170-25-105146.md) | [(0.04)](/filings/0001193125-25-270296.md) | not reported | [(0.10)](/filings/0001193125-26-209714.md) | [(0.10)](/filings/0001193125-26-338693.md) | [(0.16)](/filings/0001193125-25-270296.md) | not reported | [(0.15)](/filings/0001193125-26-209714.md) | [(0.15)](/filings/0001193125-26-338693.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [195](/filings/0000950170-23-060483.md) | [190](/filings/0000950170-25-027267.md) | [148](/filings/0000950170-24-054965.md) | [139](/filings/0000950170-24-092133.md) | [158](/filings/0000950170-24-122605.md) | [142](/filings/0001193125-26-083569.md) | [166](/filings/0000950170-25-067208.md) | [502](/filings/0000950170-25-105146.md) | [395](/filings/0001193125-25-270296.md) | [396](/filings/0001193125-26-338693.md) | [506](/filings/0001193125-26-209714.md) | [432](/filings/0001193125-26-338693.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [195](/filings/0000950170-23-060483.md) | [190](/filings/0000950170-25-027267.md) | [148](/filings/0000950170-24-054965.md) | [139](/filings/0000950170-24-092133.md) | [158](/filings/0000950170-24-122605.md) | [142](/filings/0001193125-26-083569.md) | [166](/filings/0000950170-25-067208.md) | [502](/filings/0000950170-25-105146.md) | [395](/filings/0001193125-25-270296.md) | [397](/filings/0001193125-26-338693.md) | [511](/filings/0001193125-26-209714.md) | [432](/filings/0001193125-26-338693.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [0.1](/filings/0000950170-23-060483.md) | [0.1](/filings/0000950170-25-027267.md) | [0.1](/filings/0000950170-24-054965.md) | [0.0](/filings/0000950170-24-092133.md) | [0.1](/filings/0000950170-24-122605.md) | [0.0](/filings/0001193125-26-083569.md) | [0.1](/filings/0000950170-25-067208.md) | [0.2](/filings/0000950170-25-105146.md) | [0.2](/filings/0001193125-25-270296.md) | [0.3](/filings/0001193125-26-338693.md) | [5.7](/filings/0001193125-26-209714.md) | [0.2](/filings/0001193125-26-338693.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(174) d](/filings/0000950170-24-122605.md) | [38.4 d](/filings/0000950170-25-027267.md) | [49.3](/filings/0000950170-25-067208.md) | [(29.4) d](/filings/0000950170-25-105146.md) | [(51.6) d](/filings/0001193125-25-270296.md) | [(70.2) d](/filings/0001193125-26-083569.md) | [(126)](/filings/0001193125-26-209714.md) | [(315) d](/filings/0001193125-26-338693.md) | [(562) d](/filings/0001193125-25-270296.md) | [(536) d](/filings/0001193125-26-083569.md) | [(617)](/filings/0001193125-26-209714.md) | [(717) d](/filings/0001193125-26-338693.md) |
| Dividends paid | $k | not reported | not reported | [48.5](/filings/0000950170-25-067208.md) | [6.2](/filings/0000950170-25-105146.md) | [0.0 d](/filings/0001193125-25-270296.md) | [0.0 d](/filings/0001193125-26-083569.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,486](/filings/0000950170-23-060483.md) | [2,154](/filings/0000950170-24-054965.md) | [1,916](/filings/0000950170-24-092133.md) | [1,776](/filings/0000950170-24-122605.md) | [1,692](/filings/0000950170-25-067208.md) | [1,486](/filings/0000950170-25-105146.md) | [1,437](/filings/0001193125-25-270296.md) | [1,439](/filings/0001193125-26-209714.md) | [4,074](/filings/0001193125-26-338693.md) | [3,682](/filings/0001193125-25-270296.md) | [4,433](/filings/0001193125-26-209714.md) | [4,384](/filings/0001193125-26-338693.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,950,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338693.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.